Global Neuromodulation Market Research Report 2018

September 2018 | 102 pages | ID: G44D9DF45C0EN
DPI Research

Abstracts

Global Neuromodulation market is set to surpass US$ 7 Billion by 2025

With such an extensive therapeutic scope, and immense ongoing enhancements in biotechnology, neuromodulation will likely be a leading growth industry over the forecast period. The growth of the sector is largely stimulated by an increased uptake of neuromodulation devices, surging prevalence of diseases pertaining to neuromodulation, ageing population, technological advances and deal making activity globally.

The report titled “Global Neuromodulation Market Research Report 2018” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the Global Neuromodulation Market.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides in-depth analysis and information according to categories such as application, technology, geography, company and competitive landscape.A comprehensive analysis has been done on market share of all the categories.Key trends in terms of merger & acquisitions, collaborations, partnerships and agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Neuromodulation market.

The report concludes with the profiles of major players in the Neuromodulation market. The major market players are evaluated on various parameters such as company overview, product portfolios, market revenue and recent development of the Neuromodulation market.

Further key findings from the report suggest:

• North America is the most attractive market in the neuromodulation market
• Chronic pain is the major application segment of the neuromodulation market
• With regard to technology, spinal cord stimulation represents the largest segment of the neuromodulation market
• The APAC marketplace is slated to grow at the highest rate, and China, India and Japan will be major igniters

Market Segmentation: Global Neuromodulation Market

The global neuromodulation market has been segmented on the basis of technology, application, geographyand company

Neuromodulation Market, by Technology

• Spinal Cord Stimulation (SCS)
• Deep Brain Stimulation (DBS)
• Sacral Nerve Stimulation (SNS)
• Vagus Nerve Stimulation (VNS)
• Other Technologies

Neuromodulation Market, by Application

• Chronic Pain
• Parkinson’s Disease
• Urinary Fecal Incontinence
• Refractory Epilepsy
• Essential Tremor
• Dystonia
• Gastroparesis
• Treatment Resistant Depression (TRD)
• Obsessive Compulsive Disorder (OCD)
• Other Applications

Neuromodulation Market, by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Rest of the World (ROW)

Neuromodulation Market, by Company

• Medtronic
• Boston Scientific
• St. Jude Medical (Abbott)
• LivaNova
• Nevro
• Other Companies

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL NEUROMODULATION MARKET ANALYSIS & FORECAST (2013 – 2025)

3. MARKET SHARE ANALYSIS OF NEUROMODULATION MARKET (%),2017

3.1 Global Neuromodulation Market Share, By Technology
3.2 Global Neuromodulation Market Share, By Region
3.3 Global Neuromodulation Market Share, By Application
3.4 Global Neuromodulation Market Share, By Company

4. KEY MARKET DRIVERS AND INHIBITORS OF THE NEUROMODULATION MARKET

4.1 Market Drivers
4.2 Market Inhibitors

5. GLOBAL NEUROMODULATION MARKET SIZE & FORECAST, BY TECHNOLOGY (2013 – 2025)

5.1 Spinal Cord Stimulation
5.2 Deep Brain Stimulation
5.3 Sacral Nerve Stimulation
5.4 Vagus Nerve Stimulation
5.5 Other Technologies

6. GLOBAL NEUROMODULATION MARKET SIZE & FORECAST, BY REGION (2013 – 2025)

6.1 North America
6.2 Europe
6.3 Asia Pacific
6.4 Latin America
6.5 Rest of the World (ROW)

7. GLOBAL NEUROMODULATION MARKET SIZE & FORECAST, BY APPLICATION (2013 – 2025)

7.1 Chronic Pain
7.2 Parkinson’s Disease
7.3 Urinary Fecal Incontinence (UFI)
7.4 Refractory Epilepsy
7.5 Essential Tremor
7.6 Dystonia
7.7 Gastroparesis
7.8 Treatment Resistant Depression (TRD)
7.9 Obsessive Compulsive Disorder (OCD)
7.10 Other Application

8. MAJOR DEALS IN THE NEUROMODULATION MARKET

8.1 Mergers & Acquisitions
8.2 Agreements, Collaborations & Partnerships

9. KEY COMPANIES ANALYSIS

9.1 Medtronic
  9.1.1 Business Overview
  9.1.2 Neuromodulation Products Portfolio
  9.1.3 Neuromodulation Sales Analysis & Forecast
  9.1.4 Recent Development
9.2 Boston Scientific
  9.2.1 Business Overview
  9.2.2 Neuromodulation Products Portfolio
  9.2.3 Neuromodulation Sales Analysis & Forecast
  9.2.4 Recent Development
9.3 St Jude Medical (Abbott)
  9.3.1 Business Overview
  9.3.2 Neuromodulation Products Portfolio
  9.3.3 Neuromodulation Sales Analysis & Forecast
  9.3.4 Recent Development
9.4 Liva Nova (Cyberonics)
  9.4.1 Business Overview
  9.4.2 Neuromodulation Products Portfolio
  9.4.3 Neuromodulation Sales Analysis & Forecast
  9.4.4 Recent Development
9.5 Nevro
  9.5.1 Business Overview
  9.5.2 Neuromodulation Products Portfolio
  9.5.3 Neuromodulation Sales Analysis & Forecast
  9.5.4 Recent Development

List Of Tables

LIST OF TABLES

Table 7–1: Neuromodulation Market – Merger & Acquisitions (Million US$),2011 – 2016
Table 7–2: Neuromodulation Market – Partnerships, Collaboration & Distribution Agreement,2009 – 2016

List Of Figures

LIST OF FIGURES

Figure 2–1: Global Neuromodulation Market (Million US$),2013 - 2017
Figure 2–2: Global Neuromodulation Market Forecast (Million US$),2018 - 2025
Figure 3–1: By Technology Neuromodulation Market Share Outlook (Percent), 2017
Figure 3–2: By Region Neuromodulation Market Share Outlook (Percent),2017
Figure 3–3: By Application Neuromodulation Market Share Outlook (Percent),2017
Figure 3–4: By Company Neuromodulation Market Share Outlook (Percent),2017
Figure 4–1: Global Ageing Population & Forecast (Million), 2010 – 2050
Figure 5–1: Global Spinal Cord Stimulation Market Revenue (Million US$),2013 - 2017
Figure 5–2: Global Spinal Cord Stimulation Market Revenue Forecast (Million US$),2018 - 2025
Figure 5–3: Global Deep Brain Stimulation Market Revenue (Million US$),2013 - 2017
Figure 5–4: Global Deep Brain Stimulation Market Revenue Forecast (Million US$),2018 - 2025
Figure 5–5: Global Sacral Nerve Stimulation Market Revenue (Million US$),2013 - 2017
Figure 5–6: Global Sacral Nerve Stimulation Market Revenue Forecast (Million US$),2018 - 2025
Figure 5–7: Global Vagus Nerve Market Revenue (Million US$),2013 - 2017
Figure 5–8: Global Vagus Nerve Market Revenue Forecast (Million US$),2018 - 2025
Figure 5–9: Global Other Technologies Market Revenue (Million US$),2013 - 2017
Figure 5–10: Global Other Technologies Market Revenue Forecast (Million US$),2018 - 2025
Figure 6–1: North America Neuromodulation Market Revenue (Million US$),2013 - 2017
Figure 6–2: North America Neuromodulation Market Revenue Forecast (Million US$),2018 - 2025
Figure 6–3: Europe Neuromodulation Market Revenue (Million US$),2013 - 2017
Figure 6–4: Europe Neuromodulation Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6–5: Asia Pacific Neuromodulation Market Revenue (Million US$),2013 - 2017
Figure 6–6: Asia Pacific Neuromodulation Market Revenue Forecast (Million US$),2018 - 2025
Figure 6–7: Latin America Neuromodulation Market Revenue (Million US$),2013 - 2017
Figure 6–8: Latin America Neuromodulation Market Revenue Forecast (Million US$),2018 - 2025
Figure 6–9: ROW Neuromodulation Market Revenue (Million US$),2013 - 2017
Figure 6–10: ROW Neuromodulation Market Revenue Forecast (Million US$),2018 - 2025
Figure 7–1: Chronic Pain Neuromodulation Market Revenue (Million US$), 2013 - 2017
Figure 7–2: Chronic Pain Neuromodulation Market Revenue Forecast (Million US$),2018 - 2025
Figure 7–3: Parkinson’s Disease Neuromodulation Market Revenue (Million US$),2013 - 2017
Figure 7–4: Parkinson’s Disease Neuromodulation Market Revenue Forecast (Million US$),2018 - 2025
Figure 7–5: UFI Neuromodulation Market Revenue (Million US$),2013 - 2017
Figure 7–6: UFI Neuromodulation Market Revenue Forecast (Million US$),2018 - 2025
Figure 7–7: Refractory Epilepsy Neuromodulation Market (Million US$),2013 - 2017
Figure 7–8: Refractory Epilepsy Neuromodulation Market Forecast (Million US$),2018 - 2025
Figure 7–9: Essential Tremor Neuromodulation Market (Million US$),2013 - 2017
Figure 7–10: Essential Tremor Neuromodulation Market Forecast (Million US$),2018 - 2025
Figure 7–11: Dystonia Neuromodulation Market (Million US$),2013 - 2017
Figure 7–12: Dystonia Neuromodulation Market Forecast (Million US$),2018 - 2025
Figure 7–13: Gastroparesis Neuromodulation Market (Million US$),2013 - 2017
Figure 7–14: Gastroparesis Neuromodulation Market Forecast (Million US$),2018 - 2025
Figure 7–15: TRD Neuromodulation Market (Million US$),2013 - 2017
Figure 7–16: TRD Neuromodulation Market Forecast (Million US$),2018 - 2025
Figure 7–17: OCD Neuromodulation Market (Million US$),2013 - 2017
Figure 7–18: OCD Neuromodulation Market Forecast (Million US$),2018 - 2025
Figure 7–19: Other Application Neuromodulation Market & Forecast (Million US$),2013 - 2017
Figure 7–20: Other Application Neuromodulation Market Forecast (Million US$),2018 - 2025
Figure 9–1: Medtronic Neuromodulation Sales Analysis (Million US$),2013 - 2017
Figure 9–2: Medtronic Neuromodulation Sales Analysis Forecast (Million US$),2018 - 2025
Figure 9–3: Boston Scientific Neuromodulation Sales Analysis (Million US$),2013 - 2017
Figure 9–4: Boston Scientific Neuromodulation Sales Analysis Forecast (Million US$),2018 - 2025
Figure 9–5: St Jude Medical Neuromodulation Sales Analysis (Million US$),2013 - 2017
Figure 9–6: St Jude Medical Neuromodulation Sales Analysis Forecast (Million US$),2018 - 2025
Figure 9–7: Liva Nova Neuromodulation Sales Analysis (Million US$),2013 - 2017
Figure 9–8: Liva Nova Neuromodulation Sales Analysis Forecast (Million US$),2018 - 2025
Figure 9–9: Nevro Neuromodulation Sales Analysis (Million US$),2013 – 2017
Figure 9–10: Nevro Neuromodulation Sales Analysis Forecast (Million US$),2018 - 2025